Results 11 to 20 of about 10,365 (241)

Proliferative vitreoretinopathy and its relationship with inflammatory serum biomarkers [PDF]

International Journal of Ophthalmology
AIM: To analyze if a relationship between levels of inflammatory serum biomarkers and severity of primary proliferative vitreoretinopathy (PVR) exists. METHODS: A retrospective case-control study.
Victor Alejandro Martinez Pacheco, Sergio Rojas Juarez, Braulio Hernan Velasco Sepulveda, Abel Ramirez Estudillo   +3 more
doaj   +2 more sources

Proliferative Vitreoretinopathy in Retinal Detachment: Perspectives on Building a Digital Twin Model Using Nintedanib. [PDF]

Int J Mol Sci
Proliferative vitreoretinopathy (PVR) is a pathological process characterized by the formation of fibrotic membranes that contract and lead to recurrent retinal detachment. Pars plana vitrectomy (PPV) is the primary treatment, but recurrence rates remain
Visioli G, Romaniello A, Spinoglio L, Albanese GM, Iannetti L, Gagliardi OM, Lambiase A, Gharbiya M.   +7 more
europepmc   +3 more sources

Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study [PDF]

, 2021
Objective: The objective of this pilot study was to evaluate the efficacy and safety of per-operative intravitreal methotrexate (MTX) infusion during vitrectomy in patients of retinal detachment (RD) with advanced grade proliferative vitreoretinopathy ...
Sana Jahangir, Tehmina Jahangir, Muhammad Hassaan Ali, Qasim Lateef, Uzma Hamza, Haroon Tayyab   +5 more
openalex   +4 more sources

Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial [PDF]

Scientific Reports
In this randomized controlled trial, we assessed the effects of three consecutive intra-silicone oil (SO) injections of methotrexate (MTX) on the outcomes of surgery for proliferative vitreoretinopathy grade C (PVR-C).
Ramin Nourinia, Sare Safi, Mehrad Mohammadpour, Hamid Riazi-Esfahani, Mohammad Reza Ansari Astaneh, Khalil Ghasemi Falavarjani, Alireza Ramezani, Saeed Karimi, Sahba Fekri, Nazanin Ebrahimiadib, Elias Khalili Pour, Homayoun Nikkhah, Nasser Shoeibi, Narges Hassanpoor, Maryam Hosseini, Mojtaba Abrishami, Fatemeh Abdi, Anoushiravan Rahimi, Mohammad Hossein Jabbarpoor Bonyadi, Siamak Moradian, Sina Khosravi Mirzaei, Hamid Safi, Pasha Anvari, Kaveh Fadakar, Masoud Mirghorbani, Niloufar Mohammadbagheri, Firouze Hatami, Bahareh Kheiri, Mehdi Yaseri, Zahra Khorrami, Hamid Ahmadieh   +30 more
doaj   +2 more sources

Risk factors for failure after primary vitrectomy with no scleral buckling for rhegmatogenous retinal detachment [PDF]

Revista Brasileira de Oftalmologia, 2023
Objective To assess pre-operative conditions that could influence primary anatomical success rate in a cohort of patients with rhegmatogenous retinal detachments (RRD) treated with primary vitrectomy and no scleral buckling.
Mariano Iros, Juan Manuel Lopez, Nicolás Crim, Evangelina Espósito, Julio A. Urrets-Zavalía   +4 more
doaj   +1 more source

Effect of Adjuvant Mitomycin-C on Recurrent Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy Managed by Relaxing Retinotomy and Retinectomy. [PDF]

J Ophthalmol
Purpose: To evaluate the role of adjuvant mitomycin‐C (MMC) use in cases of recurrent rhegmatogenous retinal detachment (RRD) complicated by proliferative vitreoretinopathy (PVR) managed by relaxing retinotomy and retinectomy (RR). Methods: A retrospective analysis of consecutive patients undergoing vitreoretinal surgery with RR for RD and PVR was ...
Gürelik İG, Özdemir HB, Köse BG, Acar AB.   +3 more
europepmc   +2 more sources

Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes. [PDF]

Int J Mol Sci, 2023
Bonente D, Bianchi L, De Salvo R, Nicoletti C, De Benedetto E, Bacci T, Bini L, Inzalaco G, Franci L, Chiariello M, Tosi GM, Bertelli E, Barone V.   +12 more
europepmc   +3 more sources

Proliferative vitreoretinopathy and it’s prevention in cases of extensive penetrating wounds of the sclera

Офтальмохирургия, 2023
Relevance. Currently, there is no single algorithm for the management of patients with extensive penetrating wounds of the sclera, and the frequency of proliferative vitreoretinopathy, leading to adverse outcomes, is very high. Purpose.
S.S. Shamkin, S.N. Subbotina
doaj   +1 more source

Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy

Case Reports in Ophthalmology, 2022
Our case emphasizes the approach of a single-dose of intraoperative methotrexate (MTX) – applied directly into silicone oil – to arrest the anomalous progression of proliferative vitreoretinopathy (PVR).
Adrian Babel, Eric K. Chin, David R.P. Almeida   +2 more
doaj   +1 more source

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. [PDF]

Int J Mol Sci, 2023
Datlibagi A, Zein-El-Din A, Frohly M, Willermain F, Delporte C, Motulsky E.   +5 more
europepmc   +3 more sources